Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jeffrey V. Ravetch

FcγRs Modulate the Anti-Tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis

Cancer Cell

English

Related publications

Prognostic Significance of Pd-L1 and Phosphorylated Erk Expression in T-Cell Lymphoma: Pd-1/Pd-L1 Axis Activates Intracellular Erk Signaling in Tumor Cells

Hematological Oncology

English

The Role of PD-1/PD-L1 Axis in Treg Development and Function: Implications for Cancer Immunotherapy

OncoTargets and Therapy

Oncology

Pharmacology

2019

English

Targeting the PD1/PD-L1 Axis in Melanoma: Biological Rationale, Clinical Challenges and Opportunities

Critical Reviews in Oncology/Hematology

English

PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients

Journal of Pathology and Translational Medicine

English

Macrophage PD-L1 Strikes Back: PD-1/PD-L1 Interaction Drives Macrophages Toward Regulatory Subsets

Advances in Bioscience and Biotechnology

2013

English

Poor Outcome With Anti-Programmed Death-Ligand 1 (PD-L1) Antibody Due to Poor Pharmacokinetic Properties in PD-1/PD-L1 Blockade-Sensitive Mouse Models

Journal for ImmunoTherapy of Cancer

English

Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment

International Journal of Clinical Oncology

English

The Importance of the PD-1/PD-L1 Pathway at the Maternal-Fetal Interface

BMC Pregnancy and Childbirth

Gynecology

Obstetrics

2019

English

Positron Emission Tomography Imaging of the PD-1/PD-L1 Checkpoint in Naïve and Irradiated Tumor-Bearing Mice

International Journal of Radiation Oncology Biology Physics

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jeffrey V. Ravetch

FcγRs Modulate the Anti-Tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis

Related publications

Prognostic Significance of Pd-L1 and Phosphorylated Erk Expression in T-Cell Lymphoma: Pd-1/Pd-L1 Axis Activates Intracellular Erk Signaling in Tumor Cells

The Role of PD-1/PD-L1 Axis in Treg Development and Function: Implications for Cancer Immunotherapy

Targeting the PD1/PD-L1 Axis in Melanoma: Biological Rationale, Clinical Challenges and Opportunities

PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients

Macrophage PD-L1 Strikes Back: PD-1/PD-L1 Interaction Drives Macrophages Toward Regulatory Subsets

Poor Outcome With Anti-Programmed Death-Ligand 1 (PD-L1) Antibody Due to Poor Pharmacokinetic Properties in PD-1/PD-L1 Blockade-Sensitive Mouse Models

Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment

The Importance of the PD-1/PD-L1 Pathway at the Maternal-Fetal Interface

Positron Emission Tomography Imaging of the PD-1/PD-L1 Checkpoint in Naïve and Irradiated Tumor-Bearing Mice